Brief: Cerenis End-March Cash And Cash Equivalents At 9.7 Million Euros
April 18 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
CEREN.PA :
* CERENIS THERAPEUTICS: CASH POSITION AND ACTIVITY UPDATE
FOR Q1
2019
* ANNOUNCES TODAY THAT CASH AND CASH EQUIVALENTS TOTALED EUR
9.7
MILLION AT MARCH 31, 2019
* COMPANY HAVING NOT GENERATED ANY REVENUE DURING 1(ST)
QUARTER OF
2019
* DISCUSSIONS ARE UNDERWAY FOR ITS PRODUCT CER-002
Source text for Eikon: ID:nBwfpYL1a
Further company coverage: CEREN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls